Freezing of gait in Parkinson's disease: The paradoxical interplay between gait and cognition

Parkinsonism and Related Disorders

Volumn 20, Issue 8, 2014, Pages 824-829

  Ricciardi, Lucia ^a,b   Bloem, Bastiaan R ^c   Snijders, Anke H ^c   Daniele, Antonio ^d   Quaranta, Davide ^d   Bentivoglio, Anna Rita ^d   Fasano, Alfonso ^e  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cognition; Executive functions; Freezing of gait; Gait; Parkinson's disease

Indexed keywords

LEVODOPA;

AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; FREEZING OF GAIT; GAIT DISORDER; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PHONETICS; PRIORITY JOURNAL; REST; TASK PERFORMANCE; WALKING; COMPLICATION; EXECUTIVE FUNCTION; GAIT; GAIT DISORDERS, NEUROLOGIC; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

AGED; COGNITION; EXECUTIVE FUNCTION; FEMALE; GAIT; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84905245462     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.04.009     Document Type: Article

References (33)

1. Yogev-Seligmann G., Hausdorff J.M., Giladi N. The role of executive function and attention in gait. Mov Disord 2008, 23:329-342.
2. Giladi N., Nieuwboer A. Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord 2008, 23(Suppl.2):S423-S425.
3. Schaafsma J.D., Balash Y., Gurevich T., Bartels A.L., Hausdorff J.M., Giladi N. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol 2003, 10:391-398.
4. Espay A.J., Fasano A., van Nuenen B.F.L., Payne M., Snijders A.H., Bloem B.R. "On" state freezing of gait in Parkinson's disease: a paradoxical levodopa-induced complication. Neurology 2012, 78:454-457.
5. Amboni M., Cozzolino A., Longo K., Picillo M., Barone P. Freezing of gait and executive functions in patients with Parkinson's disease. Mov Disord 2008, 23:395-400.
6. Naismith S.L., Shine J.M., Lewis S.J. The specific contributions of set-shifting to freezing of gait in Parkinson's disease. Mov Disord 2010, 25:1000-1004.
7. Spildooren J., Vercruysse S., Desloovere K., Vandenberghe W., Kerckhofs E., Nieuwboer A. Freezing of gait in Parkinson's disease: the impact of dual-tasking and turning. Mov Disord 2010, 25:2563-2570.
8. Heremans E., Nieuwboer A., Spildooren J., Vandenbossche J., Deroost N., Soetens, et al. Cognitive aspects of freezing of gait in Parkinson's disease: a challenge for rehabilitation. JNeural Transm 2013 Apr, 120(4):543-557.
9. Kostic V.S., Agosta F., Pievani M., Stefanova E., Jecmenica-Lukic M., Scarale A., et al. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology 2012 Feb 7, 78(6):409-416.
10. Tessitore A., Amboni M., Esposito F., Russo A., Picillo M., Marcuccio L., et al. Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. Parkinsonism Relat Disord 2012 Jul, 18(6):781-787.
11. Plotnik M., Giladi N., Hausdorff J.M. Bilateral coordination of gait and Parkinson's disease: the effects of dual tasking. JNeurol Neurosurg Psychiatry 2009, 80:347-350.
12. Shine J.M., Naismith S.L., Palavra N.C., Lewis S.J., Moore S.T., Dilda V., et al. Attentional set-shifting deficits correlate with the severity of freezing of gait in Parkinson's disease. Parkinsonism Relat Disord 2013 Mar, 19(3):388-390.
13. Kudlicka A., Clare L., Hindle J.V. Executive functions in Parkinson's disease: systematic review and meta-analysis. Mov Disord 2011 Nov, 26(13):2305-2315.
14. Ferraye M.U., Ardouin C., Lhommee E., Fraix V., Krack P., Chabardès S., et al. Is there a relation between FOG and cognitive decline in Parkinson's disease?. Parkinsonism Relat Disord 2008, 14:S24-S25.
15. Snijders A.H., Leunissen I., Bakker M., Overeem S., Helmich R.C., Bloem B.R., et al. Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain 2011, 134:59-72.
16. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
17. Giladi N., Shabtai H., Simon E.S., Biran S., Tal J., Korczyn A.D. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 2000, 6:165-170.
18. Fahn S., Elton R. Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 2:153-163. Macmillan Health Care Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D.B. Calne (Eds.).
19. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2653.
20. Amboni M., Barone P., Picillo M., Cozzolino A., Longo K., Erro R., et al. Atwo-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. Mov Disord 2010, 25:793-795.
21. Lewis S.J., Barker R.A. Apathophysiological model of freezing of gait in Parkinson's disease. Parkinsonism Relat Disord 2009, 15:333-338.
22. Nantel J., McDonald J.C., Tan S., Bronte-Stewart H. Deficits in visuospatial processing contribute to quantitative measures of freezing of gait in Parkinson's disease. Neuroscience 2012 Sep 27, 221:151-156.
23. Cowie D., Limousin P., Peters A., Hariz M., Day B.L. Doorway-provoked freezing of gait in Parkinson's disease. Mov Disord 2012 Apr, 27(4):492-499.
24. Cowie D., Limousin P., Peters A., Day B.L. Insights into the neural control of locomotion from walking through doorways in Parkinson's disease. Neuropsychologia 2010, 48:2750-2757.
25. Hanakawa T., Fukuyama H., Katsumi Y., Honda M., Shibasaki H. Enhanced lateral premotor activity during paradoxical gait in Parkinson's disease. Ann Neurol 1999, 45:329-336.
26. Harley C., Wilkie R.M., Wann J.P. Stepping over obstacles: attention demands and aging. Gait Posture 2009, 29:428-432.
27. Swanson J., Baler R.D., Volkow N.D. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology 2011, 36(1):207-226.
28. Bloem B.R., Grimbergen Y.A., van Dijk J.G., Munneke M. The "posture second" strategy: a review of wrong priorities in Parkinson's disease. JNeurol Sci 2006, 248:196-204.
29. Shine J.M., Moustafa A.A., Matar E., Frank M.J., Lewis S.J. The role of frontostriatal impairment in freezing of gait in Parkinson's disease. Front Syst Neurosci 2013 Oct 4, 7:61.
30. Devos D., Defebvre L., Bordet R. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease. Fundam Clin Pharmacol 2010, 24:407-421.
31. Jankovic J. Atomoxetine for freezing of gait in Parkinson disease. JNeurol Sci 2009, 284:177-178.
32. Morgante F., Fasano A. Improvement with duloxetine in primary progressive freezing gait. Neurology 2010, 75:2130-2132.
33. Thevathasan W., Cole M.H., Graepel C.L., Hyam J.A., Jenkinson N., Brittain J.S., et al. Aspatiotemporal analysis of gait freezing and the impact ofpedunculopontine nucleus stimulation. Brain 2012 May, 135(Pt 5):1446-1454.